The MIRO II Study: Microbial Restoration in Inflammatory Bowel Diseases
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, two-centre, double-blind, parallel-arm, randomised, placebo-controlled
trial evaluating the impact of FMT on patients with active Crohn's disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
St Vincent's Hospital Melbourne
Collaborators:
BiomeBank Adelaide Monash University The Queen Elizabeth Hospital The University of Queensland